Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector




















Sort by: Date|Relevance

R-Word Index, Google Trends and Gold

Everyone is discussing recession right now. But how much do they actually chatter about it? Does this talk reflect or change people’s perception? And the key question is: can the world-related indices predict the recession? Are they useful for the precious me...

Gold Clearly Reverses at Consolidation’s Upper Border

Quite a few journalists wrote about gold’s breakout in the previous days even though gold made an attempt to break above the key resistance – the mid-2013 high – only today (and it failed). At the same time, when the gold to silver ratio was breaking out in a c...

How to Unrig the Gold Market, According to GATA’s Chris Powell

In an earlier post, I gave you a sneak preview of my interview with Chris Powell, secretary/treasurer at Gold Anti-Trust Action Committee (GATA). For 20 years now, Chris and others at GATA have made it their mission to expose collusion by international financial institutions...

Flying Under the Radar with a Possible COVID-19 Treatment

Investors would think a pharmaceutical company heading into Phase 2b/3 human trials for treating the third most malignant disease after lung cancer and pancreatic cancer would draw eyes from major players. If that same company announced it was embarking on Phase2b/3 human tri...

Blacktop politics

Benjamin Franklin once said; “Out of adversity comes opportunity.” The adversity the United States now faces with the coronavirus pandemic is the worst national emergency the country has faced since World War II, more serious, far more deadly, than a...

Covid-19: Who, what, when, where and why

If there is one thing we know about the coronavirus, it’s that getting a jump on it helps to limit the number of infections. Clearly the best time to stop this, and all outbreaks, is in its early stages. Both China and the United States have been accused of...

Buzz on the Bullboards: Making news, before it becomes a headline

Energy stocks slid on lower crude oil prices of late, keeping Canada’s resource-heavy main stock index on the lower side over the past few days, though the TSX has been pushing a rebound of...

Silvercorp Metals Inc. – A Decade of Value Generation

By Dr. Ryan D. Long Over the past 10 years Silvercorp Metals…

MagIndustries (T.MAA) up 12% on China funding news

Top Bullboards post: “Wow. I feel so sorry for those that have braved this nasty story . Myself included. I honestly thought this was it for all of you. I will disclose I have no interest in this company any longer and no I do not have any inside knowledge,&CloseCurlyQu...

VIDEO: FSD Pharma CEO Raza Bokhari updates investors on ‘HUGE’ news

FSD Pharma Inc. ( CSE: HUGE , OTCQB: FSDDF , Forum ) is focused on the research and development of novel cannabinoid-based treatments for several central nervous system disorders including chronic pain, fibromyalgia and irritable bowel syndrome, and on the deve...
1 2 3 4 5 6 7 8 9 10 ...